Literature DB >> 1751235

Characterizing sleep disorders in chronic hemodialysis patients.

J L Holley1, S Nespor, R Rault.   

Abstract

Forty-eight chronic hemodialysis (HD) patients (pts) completed questionnaires that used linear analogue scales (LAS), yes/no responses, and demographic data collection to characterize sleep disorders. Twenty-five pts (52%) reported problems sleeping. These pts graded sleep problems significantly higher than those without sleep problems (6.5 +/- 3 vs. 1.8 +/- 2, p less than 0.001 by LAS). Those with sleep disorders were more likely to smoke cigarettes (13/25 vs. 6/23, p less than 0.05) and have bone pain (14/25 vs. 6/23, p less than 0.05). No differences among pts with and without sleep problems were seen in age, gender, time on dialysis, caffeine intake, pruritus, feelings of sadness, worry, or anxiety, or Kt/V values (1.5 +/- 0.2 vs. 1.4 +/- 0.2, p less than 0.13). Restless legs (84%), onset insomnia (76%), and nighttime (76%) and early A.M. waking (72%) characterized the sleep disorders; symptoms suggesting nocturnal myoclonus were less common (20%). We conclude that sleep disorders are common in HD pts and may be exacerbated by tobacco use, bone pain, and restless legs. Kt/V does not correlate with sleep disorders. Further examination of this problem, including formal sleep studies, is needed.

Entities:  

Mesh:

Year:  1991        PMID: 1751235

Source DB:  PubMed          Journal:  ASAIO Trans        ISSN: 0889-7190


  10 in total

Review 1.  Health related quality of life in patients with chronic kidney disease.

Authors:  Kamyar Kalantar-Zadeh; Mark Unruh
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

2.  Executive summary of the KDIGO Controversies Conference on Supportive Care in Chronic Kidney Disease: developing a roadmap to improving quality care.

Authors:  Sara N Davison; Adeera Levin; Alvin H Moss; Vivekanand Jha; Edwina A Brown; Frank Brennan; Fliss E M Murtagh; Saraladevi Naicker; Michael J Germain; Donal J O'Donoghue; Rachael L Morton; Gregorio T Obrador
Journal:  Kidney Int       Date:  2015-04-29       Impact factor: 10.612

3.  Sleep disturbances in pediatric dialysis patients.

Authors:  Ira D Davis; Joshua Baron; Mary Ann O'riordan; Carol L Rosen
Journal:  Pediatr Nephrol       Date:  2004-11-24       Impact factor: 3.714

4.  Sleep disorders in patients with end-stage renal disease undergoing dialysis: comparison between hemodialysis, continuous ambulatory peritoneal dialysis and automated peritoneal dialysis.

Authors:  Ricardo L M Losso; Gisele R Minhoto; Miguel C Riella
Journal:  Int Urol Nephrol       Date:  2014-10-31       Impact factor: 2.370

Review 5.  Restless legs syndrome.

Authors:  William G Ondo
Journal:  Curr Neurol Neurosci Rep       Date:  2005-07       Impact factor: 5.081

6.  Association of initial hemodialysis vascular access with patient-reported health status and quality of life.

Authors:  Haimanot Wasse; Nancy Kutner; Rebecca Zhang; Yijian Huang
Journal:  Clin J Am Soc Nephrol       Date:  2007-05-18       Impact factor: 8.237

7.  Restless legs syndrome in end stage renal disease patients on haemodialysis.

Authors:  Irfan Haider; Muhammad Anees; Syed Adnan Hussain Shahid
Journal:  Pak J Med Sci       Date:  2014 Nov-Dec       Impact factor: 1.088

8.  Sleep quality, daytime sleepiness and health-related quality-of-life in maintenance haemodialysis patients.

Authors:  Quanquan Shen; Xiaohong Huang; Zhaofen Luo; Xiujun Xu; Xiang Zhao; Qiang He
Journal:  J Int Med Res       Date:  2016-03-09       Impact factor: 1.671

9.  Nocturnal sleep, daytime sleepiness, and quality of life in stable patients on hemodialysis.

Authors:  Kathy P Parker; Nancy G Kutner; Donald L Bliwise; James L Bailey; David B Rye
Journal:  Health Qual Life Outcomes       Date:  2003-11-21       Impact factor: 3.186

10.  Habitual coffee consumption enhances attention and vigilance in hemodialysis patients.

Authors:  Petar M Nikić; Branislav R Andrić; Biljana B Stojimirović; Jasna Trbojevic-Stanković; Zoran Bukumirić
Journal:  Biomed Res Int       Date:  2014-05-05       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.